NORTH
CHICAGO, Ill., Sept. 6,
2024 /PRNewswire/ -- The board of directors of AbbVie
Inc. (NYSE: ABBV) today declared a quarterly cash dividend of
$1.55 per share.
The cash dividend is payable November 15,
2024, to stockholders of record at the close of business on
October 15, 2024.
Since the company's inception in 2013, AbbVie has increased its
dividend by more than 285 percent. AbbVie is a member of the
S&P Dividend Aristocrats Index, which tracks companies that
have annually increased their dividend for at least 25 consecutive
years.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines
and solutions that solve serious health issues today and address
the medical challenges of tomorrow. We strive to have a remarkable
impact on people's lives across several key therapeutic areas –
immunology, oncology, neuroscience, and eye care – and products and
services in our Allergan Aesthetics portfolio. For more information
about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on
LinkedIn, Facebook, Instagram, X (formerly Twitter), and
YouTube.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/abbvie-declares-quarterly-dividend-302240676.html
SOURCE AbbVie